Scholarly Index
Ofri Mosenzon
Regeneron (United States); 26,635 total citations; 207 total publications; best world rank #29
Regeneron (United States)
26,635Total citations
207Total publications
54H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Diabetes Treatment and Management | Lifetime | 361 | US 145 | 98.65 |
| Metabolism, Diabetes, and Cancer | Lifetime | 541 | US 249 | 98.00 |
| Diabetes Management and Research | Lifetime | 844 | US 356 | 97.37 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 29 | US 14 | 99.01 |
| Diabetes Treatment and Management | 2021-2025 | 70 | US 37 | 99.23 |
| Diabetes Management and Research | 2021-2025 | 165 | US 90 | 97.66 |
| Pancreatic function and diabetes | 2021-2025 | 214 | US 93 | 95.99 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 540 | US 163 | 89.19 |
| Pharmacology and Obesity Treatment | 2021-2025 | 173 | US 79 | 86.96 |
| Potassium and Related Disorders | 2021-2025 | 714 | US 243 | 60.31 |